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Disruption of Desmosome Assembly by Monovalent
Human Pemphigus Vulgaris Monoclonal Antibodies
Xuming Mao1, Eun Jung Choi1 and Aimee S. Payne1
The intercellular interactions of the desmosomal cadherins, desmoglein and desmocollin, are required for
epidermal cell adhesion. Pemphigus vulgaris (PV) is a potentially fatal autoimmune blistering disease
characterized by autoantibodies against desmoglein (Dsg) 3. During calcium-induced desmosome assembly,
treatment of primary human keratinocytes with pathogenic monovalent anti-Dsg3 mAbs produced from a PV
patient causes a decrease of Dsg3 and desmoplakin but not desmocollin (Dsc) 3 in the Triton-insoluble fraction
of cell lysates within 2hours. Immunofluorescence and antibody ELISA studies suggest that pathogenic mAbs
cause internalization of cell-surface Dsg3 but not Dsc3 through early endosomes. Electron microscopy
demonstrated a lack of well-formed desmosomes in keratinocytes treated with pathogenic compared to
nonpathogenic mAbs. In contrast, pathogenic mAbs caused late depletion of Dsg3 from preformed
desmosomes at 24 hours, with effects on multiple desmosomal proteins including Dsc3 and plakoglobin.
Together, these studies indicate that pathogenic PV mAbs specifically cause internalization of newly synthesized
Dsg3 during desmosome assembly, correlating with their pathogenic activity. Monovalent human PV anti-Dsg
mAbs reproduce the effects of polyclonal PV IgG on Dsg3 and will facilitate future studies to further dissect the
cellular mechanisms for the loss of cell adhesion in pemphigus.
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INTRODUCTION
Pemphigus vulgaris (PV) is a potentially life-threatening
autoimmune blistering disorder of the skin and mucous
membranes characterized by serum autoantibodies
against the desmosomal cadherins, desmoglein (Dsg) 3 and
Dsg1 (Stanley and Amagai, 2006). The pathognomonic
histologic feature of PV is suprabasilar acantholysis,
leading to the classic ‘‘tombstone’’ appearance of basal
keratinocytes that have lost both lateral and apical inter-
cellular adhesion. The serum anti-Dsg autoantibody profile
varies depending on the disease type (Ding et al., 1997;
Amagai et al., 1999). Patients with mucosal dominant PV
typically demonstrate anti-Dsg3 autoantibodies only,
whereas patients with mucocutaneous PV have circulating
autoantibodies against both Dsg3 and Dsg1. Individuals with
anti-Dsg1 autoantibodies only develop blistering in the
superficial layer of the skin in the related disease, pemphigus
foliaceus.
Desmogleins are members of the cadherin protein
superfamily, which includes the classical cadherins as well
as the desmosomal cadherins, Dsg and desmocollin (Dsc;
Getsios et al., 2004). Four Dsg isoforms and three Dsc
isoforms have been identified in humans, with each
Dsc isoform demonstrating ‘‘a’’ and ‘‘b’’ splice variants
(Kljuic et al., 2003; Whittock and Bower, 2003; Smith et al.,
2004). Dsg3 and Dsc3 are the primary desmosomal cadherins
in the basal layers of the epidermis, the site of PV pathology
(North et al., 1996; Mahoney et al., 1999). The extracellular
domain of Dsg3 can mediate weak homophilic adhesion
(Amagai et al., 1994), but heterophilic adhesion between Dsg
and Dsc is thought to form the basis of robust intercellular
desmosome adhesion (Chitaev and Troyanovsky, 1997;
Marcozzi et al., 1998; Syed et al., 2002). Intracellularly,
both Dsg and Dsc ‘‘a’’ cytoplasmic domains bind plakoglo-
bin, which links the desmosomal cadherins to the keratin
intermediate filament network through the cytoplasmic
plaque protein desmoplakin. These keratin-linked multi-
molecular structures are responsible for the characteristic
electron microscopic appearance of desmosomes (North
et al., 1999).
Epitope-mapping studies have demonstrated that patho-
genic PV antibodies tend to bind calcium-sensitive confor-
mational epitopes at the N terminus of Dsgs (Futei et al.,
2000; Sekiguchi et al., 2001). This antigenic region is
predicted to form the transadhesive interface between cells
based on homology to the crystal structure of the classic
cadherins (He et al., 2003). These and other studies have led
to the ‘‘steric hindrance’’ hypothesis of disease, in which
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pathogenic antibodies directly interfere with desmosomal
cadherin intercellular interactions. As Dsgs have been shown
to internalize in the absence of intercellular contact
(Demlehner et al., 1995), the steric hindrance model closely
ties into mechanisms of desmosome assembly and disas-
sembly (Kitajima, 2002). Previous studies have shown varying
effects of PV IgG on desmosome assembly and disassembly,
with results depending on cell confluence and the type of cell
lines used (Kitajima et al., 1987; Aoyama and Kitajima, 1999;
Sato et al., 2000; Calkins et al., 2006; Cirillo et al., 2006).
There is increasing evidence that modulators of diverse
signaling pathways can inhibit PV IgG-induced acantholysis,
including p38 mitogen-activated protein kinase (Berkowitz
et al., 2006), rho family GTPases (Waschke et al., 2006),
protein kinase C (Sanchez-Carpintero et al., 2004), and c-
myc (Williamson et al., 2006), among others (reviewed
previously, Sharma et al., 2007; Muller et al., 2008). In
addition, PV autoantibodies have been reported to target
other alternative antigens, including cholinergic receptors
and E-cadherin (Nguyen et al., 2000a, b; Evangelista et al.,
2008).
Part of the difficulty in studying pathogenic mechanisms in
PV is the lack of well-defined, reproducible anti-Dsg
autoantibody among laboratories, as serum autoantibody
profiles vary among patients and even within the same
patient over time, and the use of clinical procedures such as
plasmapheresis to obtain large volumes of patient sera is
declining. To address this issue, we and others have cloned
human pathogenic and nonpathogenic anti-Dsg3 mAbs from
patients using phage display and heterohybridoma produc-
tion, respectively (Bhol and Ahmed, 2002; Payne et al., 2005;
Yeh et al., 2006). In addition, pathogenic and nonpathogenic
anti-Dsg3 mAbs have been isolated from an active immune
mouse model of PV, in which splenocytes from Dsg3-
deficient mice are passively transferred to Rag2-deficient
mice expressing Dsg3 (Amagai et al., 2000). In a recent study,
anti-Dsg3 mAbs from the active immune mouse model of PV
did not demonstrate the same extent of Dsg3 depletion from
desmosomes as PV IgG, and the residual levels of Dsg3 did
not correlate with the adhesive strength of treated cells
(Yamamoto et al., 2007). Here, we have investigated the
effects of monovalent human PV anti-Dsg mAbs on Dsg3
incorporation into the desmosome, separately examining
desmosome assembly and disassembly pathways in primary
human epidermal keratinocytes (PHEKs). The current study
uses well-characterized and reproducible sources of patho-
genic PV anti-Dsg mAbs (Payne et al., 2005), with
nonpathogenic PV anti-Dsg mAbs as controls, to ensure that
our findings are not because of polyclonal effects of IgG or
whole sera on alternative cellular targets. In addition, we
have examined Dsg3 in comparison to its binding partner
Dsc3. The use of primary human keratinocytes as a model
system allows for correlation of subcellular fractionation and
immunofluorescence localization studies with antibody
pathogenicity. We provide evidence that monovalent PV
anti-Dsg mAbs preferentially deplete Dsg3 but not Dsc3 from
desmosomes during desmosome assembly, correlating with
their pathogenic activity.
RESULTS
Pathogenic PV mAbs preferentially deplete Dsg3 but not Dsc3
from the desmosome during calcium-induced desmosome
assembly
Calcium induction is a commonly used method for studying
desmosome assembly (Watt et al., 1984). Earlier studies have
shown that in low (o0.1mM) calcium, Dsgs are synthesized
but are rapidly endocytosed and degraded in the absence of
calcium or intercellular contact (Demlehner et al., 1995). In
high-calcium media, the half-life of Dsg increases from
approximately 4 to 24 hours, concomitant with the increased
partitioning of Dsg into the Triton X-100-insoluble fraction of
cells (Pasdar and Nelson, 1989; Williamson et al., 2006). To
characterize the localization of desmosomal cadherins in
PHEK during calcium-induced desmosome assembly, we first
examined the immunofluorescence localization of Dsg3 and
Dsc3 in PHEK grown in basal media (containing 0.07mM
calcium) and after the switch to media containing 1.2mM
calcium (Figure 1). Under low-calcium conditions (time ‘‘0’’),
both Dsg3 and the cytoplasmic plaque protein desmoplakin
are localized in an endoplasmic reticular or diffuse cyto-
plasmic pattern, with no apparent cell-surface staining.
Within 2 hours of calcium induction, cell-surface staining of
both Dsg3 as well as the cytoplasmic plaque protein
desmoplakin is apparent, with the majority of Dsg3 being
promoted to the cell membrane within 4–6 hours after
calcium induction. Interestingly, Dsc3 shows focal cell-
surface staining even under low-calcium conditions, together
with a diffuse cytoplasmic pattern. Similar to Dsg3, the
majority of Dsc3 localizes to the cell membrane in a punctate
pattern within 4 hours after calcium induction. Therefore, to
study the effects of PV mAbs on desmosome assembly, we
treated PHEK with PV mAbs at the time of calcium induction,
when the majority of Dsg molecules are translocating to the
cell surface. To study desmosome disassembly, we first
induced desmosomes in PHEK with 0.4–1.2mM calcium
media for 12–20 hours, at which time the majority of Dsg3 is
desmosomal (as evidenced by colocalization with desmo-
plakin), and then treated with PV mAbs.
The pathogenicity of the monovalent PV mAbs has been
previously characterized (Payne et al., 2005, 2007). Table S1
indicates the formal mAb name previously published, a
shortened designation used in this study based on antibody
pathogenicity (P, pathogenic, NP, nonpathogenic), and the
cadherin specificity of the mAb, including its deduced
amino-acid epitope if known. All PV mAbs recognize Dsg3.
None of the PV mAbs cross-react with Dsc3 or E-cadherin.
Although some mAbs cross-react with Dsg1, Dsg1 protein is
minimally induced in the first 24 hours after the calcium
switch (Figure S1).
We first sought to determine the effects of pathogenic and
nonpathogenic PV mAbs on desmosomal cadherins during
calcium-induced desmosome assembly. Confluent PHEK
cultures were treated with a pathogenic PV mAb (P1),
nonpathogenic PV mAb (NP1), negative control recombinant
mAb (Neg), or phosphate-buffered saline (PBS) at the time of
calcium induction. As desmosomes are known to partition
into the Triton X-100-insoluble fraction of cell lysates, at
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specified time points cells were processed to obtain the Triton
X-100-soluble and -insoluble fractions, followed by immuno-
blot analysis to determine protein levels of Dsg3 and Dsc3.
Consistent with our immunofluorescence data (Figure 1),
calcium induces a marked increase of Dsg3 in the Triton X-
100-insoluble fraction over 4 hours (Figure 2a, upper panel,
compare controls at time 0, 2, and 4 hours). The pathogenic
PV mAb (P1) causes a reduction of Dsg3 in the Triton X-100-
insoluble fraction within 2 hours of antibody treatment,
compared to nonpathogenic NP1 mAb, Neg control mAb,
and vehicle controls. This effect is more significant 4 hours
after antibody treatment. The Triton X-100 soluble fraction
demonstrates a transient increase of Dsg3 at 2 hours in
response to P1 mAb, followed by an almost complete
depletion at 4 hours after antibody treatment. Mild decreases
in plakoglobin are observed in both the soluble and insoluble
fractions. Desmoplakin is similarly reduced in the Triton X-
100-insoluble fraction 2 and 4 hours after treatment with P1
mAb (Figure 2b). In contrast, Dsc3 was not significantly
affected in the Triton X-100-soluble or -insoluble fraction by
PV mAbs.
To determine whether pathogenic PV mAbs affect
desmosomal cadherins in preassembled desmosomes, con-
fluent PHEKs were first cultured in 0.4mM calcium for
16 hours to induce desmosomes, followed by treatment with
PV mAbs. Pathogenic P1 mAb but not NP1 mAb significantly
reduces the protein level of Dsg3 in both the Triton X-100-
soluble and -insoluble fractions after 24 hours, although no
significant changes are observed 2 and 8 hours after mAb
treatment (Figure 3). Interestingly, Dsc3 and to a lesser extent
plakoglobin also decreased in the Triton X-100-insoluble
fraction in response to pathogenic P1 mAb after 24 hours.
Taken together, these data demonstrate that pathogenic PV
mAb causes an early and specific depletion of Dsg3 from the
Triton X-100-insoluble fraction of keratinocytes during
desmosome assembly, whereas pathogenic effects on Dsg3
in preformed desmosomes are delayed and associated with
depletion of multiple desmosomal molecules.
Pathogenic PV mAbs induce internalization of cell-surface Dsg3
but not Dsc3
To further investigate the mechanism by which PV mAbs
deplete Dsg3 in keratinocytes, we examined the immuno-
fluorescence localization of desmosomal cadherins in cells
treated with PV mAbs during desmosome assembly. Con-
sistent with our subcellular fractionation studies, cell-surface
Dsg3 and desmoplakin are reduced in PHEK treated with
pathogenic P1 mAb modestly at 2 hours and more signifi-
Dsg3 Desmoplakin Dsc3
Time
(hours)
0
2
4
12
Figure 1. Localization of desmosomal cadherins during calcium-induced desmosome assembly in primary human epidermal keratinocytes. PHEKs seeded on
glass coverslips in basal DK-SFM media (0.07mM calcium) were shifted to DK-SFM media containing 1.2mM calcium for the indicated amount of time.
Cells were processed for single or double-label immunofluorescence using primary antibodies specific for Dsg3 (H-145), desmoplakin, or Dsc3 (U114). Cell
nuclei were stained with DAPI. Scale bar, 10mm.
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cantly 4 hours after antibody treatment, concomitant with an
increase in cytoplasmic vesicular staining of Dsg3 (Figure 4a).
In both NP1- and P1-treated cells, linear streaks of Dsg3
staining were observed at the 2 hours time point, which may
represent recruitment of Dsg3 to nascent points of cell–cell
contact during desmosome assembly. In contrast, Dsc3 cell-
surface localization is not significantly affected by pathogenic
P1 mAb after 4 hours of antibody treatment (Figure 4b).
Antibody-induced internalization of Dsg3 correlates with PV
mAb pathogenicity
Because phage display isolated multiple PV anti-Dsg mAbs,
we were interested in characterizing whether the effects
observed for Dsg3 could be reproduced by other pathogenic
and nonpathogenic PV mAbs. During calcium-induced
desmosome assembly, both pathogenic (P1 and P2) PV
mAbs, but not two nonpathogenic (NP1 and NP2) PV mAbs,
cause a decrease of Dsg3 in both the Triton X-100-soluble
and -insoluble fraction of cell lysates after 4 hours of antibody
treatment (Figure 5a). Similarly, both P1 and P2, but not NP1
and NP2, PV mAbs cause a loss of cell-surface Dsg3 in PHEK
after 4 hours of antibody treatment (Figure 5b). Because
earlier studies have shown that PV IgG is internalized
together with Dsg3 (Calkins et al., 2006), we examined
whether pathogenic PV mAbs are more rapidly depleted from
the keratinocyte culture media than nonpathogenic PV mAbs.
PV mAbs were incubated with PHEK during calcium-induced
desmosome assembly, and aliquots of culture supernatant
were removed at the specified time points for Dsg3 ELISA.
Nonpathogenic PV mAbs demonstrated a mild decrease in
keratinocyte culture supernatants over 48 hours. However, P1
mAb was rapidly depleted from keratinocyte culture super-
natants, with moderate effects on P2 mAb (Figure 5c).
As these data suggested that cell-surface Dsg3 may be
internalized in response to pathogenic PV mAbs, we
investigated whether the cytoplasmic vesicular pattern of
Dsg3 colocalized with the early endosomal marker EEA-1.
PHEK were cultured with pathogenic P1 mAb in 1.2mM
calcium for 1 hour, followed by double-label immunofluor-
escence for the EEA-1 and the pathogenic P1 mAb, which
would be bound only to Dsg3 that had reached the cell
surface and would not label newly synthesized outgoing
Dsg3. Punctate intercellular localization of Dsg3 is observed
after 1 hour of calcium induction (Figure 6, red arrows),
representing antibody-bound cell-surface Dsg3. Significant
colocalization of EEA-1 and P1 mAb, but not NP1 mAb, is
observed beneath the plasma membrane (Figure 6, yellow
arrows). EEA-1-positive vesicles lacking Dsg3 are present,
prominent in NP1-treated cells (Figure 6, green arrows).
Taken together, these data suggest that pathogenic PV
mAbs bind newly synthesized Dsg3, preventing desmosome
assembly through internalization of Dsg3 into an early
endosomal compartment.
Interference with Dsg3 incorporation into the desmosome
inhibits calcium-induced desmosome assembly
As our immunofluorescence as well as biochemical data
demonstrated that Dsc3 was still localized to the cell surface
and the Triton X-100-insoluble fraction of cell lysates despite
depletion of Dsg3 by pathogenic PV mAbs during desmo-
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Figure 2. Pathogenic PV mAb causes loss of Dsg3 and desmoplakin but not Dsc3 from the Triton X-100-insoluble fraction of keratinocyte lysates during
calcium-induced desmosome assembly. PHEKs were treated with a pathogenic PV mAb (P1), nonpathogenic PV mAb (NP1), negative control mAb (Neg), or PBS
for the indicated amount of time during calcium-induced desmosome assembly. Equal amounts of protein from the Triton X-100-soluble and -insoluble fractions
were analyzed by SDS–PAGE, followed by immunoblotting for (a) Dsg3 (5G11) and plakoglobin, or (b) Dsc3 (U114) and desmoplakin, with keratin and
b-tubulin as loading controls.
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some assembly, we were interested in determining whether
Dsc3 alone could nucleate desmosomes through homophilic
extracellular interactions. As desmosomes are well defined at
the ultrastructural level by their characteristic appearance,
we induced PHEK with P1 and NP1 mAbs in 1.2mM calcium
media for 1 hour, followed by processing of cells for electron
microscopy. In NP1-treated cells after 1 hour of calcium
induction, multiple desmosomes were observed by electron
microscopy, demonstrating typical apposing electron dense
plaques attached to keratin intermediate filaments (Figure 7a
and b). In 1 out of 44 NP1 frames, an apparent half
desmosome was observed, although sectioning artifact of
an intact desmosome cannot be excluded (Figure 7c). In
contrast, most P1-treated PHEK demonstrated no apparent
desmosomes despite multiple areas of cell–cell contact
(Figure 7d). In some P1-treated cells, desmosome-like
structures lacking well-defined electron dense plaques were
observed (Figure 7e and f). In total, 44–49 random
intercellular frames of P1- and NP1-treated cells were
captured by an independent electron microscopy researcher,
and the number of desmosomes or desmosome-like structures
(in the case of P1-treated cells) were tallied. NP1-treated cells
demonstrate an average of 11.1 desmosomes per 10,000mm2,
and P1-treated cells demonstrate an average of 1.8 desmo-
some-like structures per 10,000mm2, with no desmosomes
demonstrating electron dense plaques. No half desmosomes
were observed in P1-treated cells. These data indicate that
interference with Dsg3 incorporation into the desmosome by
pathogenic PV mAbs disrupts overall desmosome assembly.
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Figure 3. Pathogenic PV mAb causes delayed depletion of both Dsg3 and
Dsc3 from keratinocytes demonstrating preformed desmosomes. PHEKs
were first incubated with 0.4mM calcium media overnight to stimulate
desmosome assembly, followed by treatment with a pathogenic (P1) or
nonpathogenic (NP1) PV mAb for the indicated amount of time. Equal
amounts of protein from the Triton X-100-insoluble fractions were analyzed
by SDS–PAGE, followed by immunoblotting for Dsg3 (5G11), Dsc3 (U114), or
plakoglobin, with keratin as a loading control.
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Figure 4. Pathogenic PV mAb causes loss of cell-surface Dsg3 and
desmoplakin but not Dsc3 during desmosome assembly. PHEKs were treated
with pathogenic (P1) or nonpathogenic (NP1) PV mAb during calcium-
induced desmosome assembly. At the specified time points, cells were
processed for single- or double-label immunofluorescence using primary
antibodies against (a) Dsg3 (5G11), desmoplakin, or (b) both Dsg3 (5G11) and
Dsc3 (H-50) after 4 hours of mAb treatment. Scale bar, 10 mm.
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DISCUSSION
The major finding of the current study is that monovalent
human PV anti-Dsg mAbs preferentially disrupt desmosome
assembly in human keratinocytes, correlating with their
pathogenic activity (Figures 5 and 7). We have demonstrated
that pathogenic PV mAbs cause an early depletion of Dsg3
and desmoplakin but not Dsc3 in the Triton X-100-insoluble
fraction of keratinocyte lysates during calcium-induced
desmosome assembly (Figure 2), concomitant with a loss of
cell-surface Dsg3 and desmoplakin by immunofluorescence
analysis (Figure 4). Pathogenic PV mAbs likely affect newly
synthesized (non-desmosomal) Dsg3, as they directly bind
cell-surface Dsg3 shortly after calcium induction with
subsequent internalization (Figure 6). These events result in
prevention of desmosome assembly in cells treated with
pathogenic PV mAbs by electron microscopy (Figure 7). In
contrast, pathogenic PV mAb does not demonstrate signifi-
cant effects on Dsg3 in preassembled desmosomes until
24 hours after antibody treatment, even in lower-calcium
(0.4mM) media (Figure 3). This depletion of Dsg3 is paralleled
by similar decreases in Dsc3 and plakoglobin, suggesting that
the delayed effects of PV mAbs on preformed desmosomes
are not because of specific induction of Dsg3 disassembly
from desmosomes. Instead, consistent with our electron
microscopy findings, prevention of Dsg3 incorporation into
the desmosome likely leads to destabilization of the overall
desmosomal structure, with subsequent turnover of multiple
desmosomal molecules.
Triton insolubility is a classic biochemical feature of
desmosomes. However, recent studies have suggested that
non-desmosomal Dsgs may partition into lipid rafts, which
share the biochemical property of Triton X-100 insolubility
(Nava et al., 2007; Delva et al., 2008). Immunofluorescence
allows for analysis of the overall effects of pathogenic
antibodies on subcellular localization but is suboptimal for
defining desmosomal localization, as the level of resolution is
often not sufficient to distinguish desmosomes from non-
desmosomal plasma membrane. The most well-defined
experimental definition of desmosomes is by electron
microscopy, with the classic appearance of the electron
dense cytoplasmic plaques and intercellular midline. Im-
munoelectron microscopy requires analysis of hundreds of
sections, making this approach logistically difficult for
evaluating the overall subcellular trafficking of proteins,
especially those of low cellular abundance. Given these
limitations, the subcellular localization, immunofluores-
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Figure 5. Antibody-induced depletion of Dsg3 correlates with PV mAb pathogenicity. PHEK were treated with pathogenic or nonpathogenic PV antibodies for
the indicated amount of time during calcium-induced desmosome assembly. (a) Immunoblot analysis of Dsg3 (5G11) in the Triton X-100-soluble and -insoluble
fractions of keratinocytes treated with different pathogenic (P1 and P2) and nonpathogenic (NP1 and NP2) PV mAbs. (b) Immunofluorescence analysis of
cells treated with pathogenic (P1 and P2) and nonpathogenic (NP1 and NP2) PV mAbs. Cells were stained for Dsg3 (5G11, green), and nuclei were stained with
DAPI (blue). Scale bar, 10mm. (c) The relative concentrations of PV mAbs in PHEK culture medium were monitored for 0–48 hours and measured by Dsg3 ELISA.
Data points represent mean values of four independent experiments.
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cence, and electron microscopy data presented are internally
consistent, indicating that pathogenic PV mAbs impair
assembly of Dsg3 but not Dsc3 into desmosomes.
A previous study examining anti-Dsg3 mAbs isolated from
the active immune mouse model of PV showed relatively
modest effects of individual pathogenic mAbs on depletion of
Dsg3 from the Triton X-100-insoluble fraction of cells,
although multiple mAbs in combination showed stronger
effects (Yamamoto et al., 2007), consistent with previous
reports on the synergistic pathogenicity of various anti-Dsg3
mAb combinations (Kawasaki et al., 2006). It is unclear
whether this lack of correlation is secondary to fine
differences in anti-Dsg mAb specificity across species, which
we have noted when using our human PV mAbs in neonatal
mouse passive transfer studies (Payne et al., 2005). In our
study, the immunofluorescence and biochemical findings
with human-derived PV mAbs correlate highly with PV mAb
pathogenicity in primary human keratinocytes. Although the
PV mAbs described here are monovalent single-chain
variable fragment (scFv) antibodies, initial studies using the
identical variable fragments cloned into a bivalent IgG
molecule have demonstrated similar results by immunofluor-
escence and immunoblotting (data not shown).
In all pathogenic models for PV IgG, including cultured
keratinocyte dispase assay, ex vivo human skin injection, and
passive transfer to neonatal mice, loss of cell adhesion is
observed within 1–6 hours after antibody treatment (Payne
et al., 2005; data not shown). Interestingly, the cultured
keratinocyte dispase assay is performed under conditions of
desmosome assembly, treating cells with PV mAbs at the time
of calcium induction. When desmosomes are induced before
PV IgG exposure, we and others have found that 16–24 hours
incubations with PV IgG are required for optimal pathogeni-
city (Ishii et al., 2005; Calkins et al., 2006). Both of these time
frames correspond with the time to depletion of Dsg3 in the
Triton X-100-insoluble fraction of cells under the conditions
studied, suggesting that ultimately desmosomal rather than
non-desmosomal depletion of Dsg3 is the critical pathogenic
event in PV.
Earlier studies in the field have drawn varying conclusions
regarding a primary role of PV IgG in desmosome assembly
versus disassembly. One early study suggested that PV IgG
does not inhibit calcium-induced desmosome formation in
DJM-1 squamous carcinoma cells (Kitajima et al., 1987).
However, this study only examined cytoplasmic keratin
organization, and other Dsg isoforms such as Dsg1 or Dsg2
could have nucleated functional desmosomes within these
cells. In agreement with our findings, subsequent immuno-
electron microscopy experiments suggested that PV IgG binds
cell-surface Dsg3 before desmosome incorporation, leading
to its endocytosis (Sato et al., 2000). Immunofluorescence
and subcellular fractionation experiments from different
laboratories have demonstrated that PV IgG most rapidly
affects detergent-soluble cell-surface Dsg3, although effects
on detergent-insoluble Dsg3 were not observed until 24 hours
or later (Aoyama and Kitajima, 1999; Calkins et al., 2006).
Interestingly, many studies have found a stronger effect of PV
IgG on subconfluent cells or after wounding, when desmo-
somal assembly may be the primary pathway of Dsg
trafficking. Collectively, these data appear to lend more
support to a pathogenic role of PV mAbs in desmosome
assembly as opposed to disassembly. Our data using human
anti-Dsg PV mAbs indicate that monovalent PV mAbs
reproduce the pathologic effects of bivalent PV IgG,
providing evidence that the anti-Dsg serum antibodies are
responsible for the desmosomal disruption previously ob-
served with PV IgG.
One of the strongest arguments for a role of PV IgG in
desmosome disassembly derives from immunoelectron mi-
croscopy studies in the active immune mouse model of PV
(Shimizu et al., 2004). Post-embedding labeling of oral
mucosal biopsies demonstrated in vivo mouse IgG labeling
of whole and split desmosomes without keratin retraction.
The paucity of cytoplasmic or non-desmosomal labeling
suggested that anti-Dsg antibodies primarily bind desmoso-
NP1
P1
Figure 6. Antibody-bound Dsg3 is internalized from the cell surface into
early endosomes. PHEK were treated with P1 or NP1 PV mAb during calcium-
induced desmosome assembly. After 1 hour, cells were processed for double-
label immunofluorescence using Alexa 594-conjugated primary antibodies
against the HA tag of the pathogenic PV mAb (shown in red) and Alexa 488
secondary antibodies against primary antibodies binding the early endosomal
marker EEA-1 (shown in green). Red arrows, antibody-bound cell-surface
Dsg3; yellow arrows, colocalization of internalized P1 mAb with EEA-1;
green arrows, EEA-1-positive/PV mAb-negative early endosomes. Scale bar,
10mm.
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mal Dsg3, causing disassembly through direct interference
with intercellular desmosomal cadherin interaction. How-
ever, these studies could not distinguish pathogenic from
nonpathogenic antibody labeling of desmosomal Dsg, and
other immunoelectron microscopy studies have shown that
split desmosomes observed after PV IgG treatment of cultured
keratinocytes demonstrate a reduced Dsg3-to-Dsc3 ratio,
indicating that partial depletion of Dsg3 from desmosomes
during assembly is sufficient to cause loss of functional
desmosomal adhesion (Shu et al., 2005). Ultimately, studies
on the in vivo half-life of cell-surface Dsg3 will be required to
confirm whether the pathogenic effects of PV mAbs on Dsg3
during desmosome assembly can account for the time course
of blister formation in various PV pathogenic models.
One interesting observation is that Dsc3, but not Dsg3 or
desmoplakin, demonstrates focal cell-surface staining in
basal (0.07mM) calcium media (Figure 1), indicating a
potential non-desmosomal role for cell-surface Dsc3. Earlier
studies have shown that Dsc can localize to the lateral
plasma membrane of Madin–Darby canine kidney cells
together with E-cadherin in low-calcium media, and that
Dsc is the first desmosomal cadherin to localize to the cell
surface after the switch to high-calcium media (Burdett and
Sullivan, 2002). Further studies have demonstrated that the
Dsc cytoplasmic domain can interact with b-catenin and
plakoglobin, independent of its desmosomal adhesive func-
tion (Hanakawa et al., 2000), suggesting that Dsc may
provide the link for adherens junction-dependent desmosome
assembly. A desmosome-independent biological role for
Dsc is further supported by the d6.5 embryonic lethality of
Dsc-deficient mice, before the appearance of desmosomes
(Den et al., 2006). Interestingly, the desmoplakin-null mouse
also exhibits d6.5 embryonic lethality (Gallicano et al.,
1998). An epidermal-specific deletion of desmoplakin formed
partially adhesive desmosomes, although they were function-
ally compromised (Vasioukhin et al., 2001). A non-desmo-
somal function for Dsc3 and desmoplakin could contribute to
the cell-surface staining of Dsc3 and desmoplakin observed
after pathogenic PV mAb treatment (Figure 4). Alternatively
or in addition, the poorly formed sites of keratin intermediate
filament insertion observed in Figure 7e and f could reflect
desmoplakin-bound Dsc3, which would correlate with Dsc3
and desmoplakin retention in the Triton X-100-insoluble
fraction (Figure 2b). Future immunoelectron microscopy
studies would be required to substantiate this hypothesis.
It is interesting to note the emerging parallels between
desmosomal and classical cadherin-based adhesion. Similar
to our current findings with Dsg-blocking antibodies, early
studies using E-cadherin-blocking antibodies demonstrated a
marked loss of cell-surface E-cadherin during calcium-
induced junction assembly, with more modest effects on
preformed adherens junctions (Gumbiner et al., 1988). The
regulation of cadherin adhesiveness is a complex process that
can be modulated through multiple mechanisms including
junction assembly, disassembly, and more rapid alterations in
intermolecular affinities (Gumbiner, 2000). Interestingly,
numerous signaling pathways regulating adherens junction
assembly have been implicated in PV pathogenesis, including
protein kinase C and rho family GTPases, among others
(Sharma et al., 2007; Muller et al., 2008; Waschke, 2008). It
is not surprising, therefore, that multiple chemical inhibitors
have been demonstrated to inhibit acantholysis by PV IgG,
NP1
11.1 desmosomes/
10,000 μm2
P1
1.8 desmosomes/
10,000 μm2
Figure 7. Interference with Dsg3 incorporation into the desmosome prevents calcium-induced desmosome assembly. PHEKs were treated with a pathogenic
(P1) or nonpathogenic (NP1) PV mAb during calcium-induced desmosome assembly. After 1 hour cells were processed for electron microscopy. (a) Long arrows
indicate desmosomes displaying typical electron dense plaques and keratin intermediate filament insertion. Scale bar, 2 mm. (b) Higher magnification view of
desmosomes in control NP1-treated keratinocytes. Scale bar, 1 mm. (c) One half desmosome was observed in control NP1-treated keratinocytes. Scale bar,
0.5mm. (d) In P1-treated cells, multiple points of cell–cell contact without desmosome formation were observed. Scale bar, 2 mm. (e) In rare P1-treated cells,
desmosome-like structures were observed lacking well-defined electron dense plaques (short arrows). Scale bar, 2 mm. (f) Higher magnification view of
desmosome-like structures in P1-treated cells lacking electron dense plaques. Scale bar, 0.5 mm.
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because perturbations that generally increase intercellular
adhesion (by adherens junctions or desmosomes) may be
expected to ameliorate the effects of anti-Dsg autoantibodies.
Future experiments may determine whether chemical in-
hibitors of acantholysis are specific to Dsg3 and desmosomes,
or due to modulation of other adhesion pathways. Ultimately,
these studies may broaden our understanding of cross talk
among epidermal adhesive junctions and lead to innovative
strategies for treating autoimmune blistering diseases.
MATERIALS AND METHODS
Antibodies
The production and characterization of single-chain variable
fragment PV mAbs used in these studies have been previously
described (Payne et al., 2005, 2007), including negative control
single-chain variable fragment mAbs produced in the same bacterial
recombinant system (E1M2, a human anti-red blood cell antibody,
and AM3-13).
Primary antibodies: mouse monoclonal anti-Dsg3 (5G11; Invi-
trogen, Carlsbad, CA), rabbit polyclonal anti-Dsg3 (H-145; Abcam,
Cambridge, MA), mouse anti-desmoplakin (BioDesign International,
Saco, Maine), mouse monoclonal anti-Dsc3 (Meridian Life Science
Inc., Santa Cruz, CA), rabbit polyclonal anti-Dsc3 (H-50; Santa Cruz
Biotechnology Inc., Santa Cruz, CA), mouse monoclonal anti-keratin
(Zymed, S San Francisco, CA), mouse monoclonal anti-plakoglobin
(11E4, anti-g catenin; Chemicon, Temecula, CA), mouse anti-EEA-1
(BD Biosciences, San Jose, CA), rat monoclonal anti-HA (3F10;
Roche, Nutley, NJ).
Secondary antibodies or reagents: horseradish peroxidase-
conjugated donkey anti-mouse IgG (Jackson ImmunoResearch Lab
Inc.., West Grove, PA); horseradish peroxidase-conjugated rat anti-
HA (3F10; Roche); Alexa 488-conjugated donkey anti-human IgG,
Alexa 488-conjugated goat anti-mouse and rabbit IgG, Alexa 594-
conjugated goat anti-mouse, rat, or rabbit IgG (Molecular Probes,
Invitrogen); Alexa 594-conjugated anti-HA and Alexa Fluor 633
phalloidin (Molecular Probes, Invitrogen).
Cell culture
Primary human epidermal keratinocytes (PHEK) isolated from
neonatal foreskin were expanded and stored frozen for later use by
the University of Pennsylvania Dermatology core facility. Cells from
passages 4–5 were cultured in basal defined keratinocyte-serum-free
media (DK-SFM) (Invitrogen) containing 0.07mM CaCl2 supplemen-
ted with penicillin/streptomycin. Cells were maintained in a
humidified incubator with 5% CO2 at 37 1C. For experiments on
desmosome assembly, cultures were exposed to PV mAbs
(40–100mgml1) in DK-SFM supplemented with 0.4–1.2mM CaCl2
for up to 24 hours. For experiments on desmosome disassembly,
cells were incubated with DK-SFM supplemented with 0.4–1.2mM
CaCl2 for 16–24 hours before exposure to PV mAbs.
Cell fractionation and immunoblot
Primary human epidermal keratinocytes were cultured to 90–100%
confluence in DK-SFM with 5% CO2 at 37 1C before experiments.
After treatments, cells were chilled on ice and washed with ice-cold
PBS containing calcium and magnesium (Mediatech Inc., Herndon,
VA). For analysis of Triton X-100-soluble or -insoluble fractions, cells
were initially lyzed in buffer containing 1% Triton X-100, 10mM
Tris-HCl (pH 7.5), 140mM NaCl, 5mM EDTA, 2mM EGTA, with
protease inhibitors (P8340; Sigma, Saint Louis, MO) for 15minutes
on ice, followed by centrifugation at 16,000 g for 20minutes at 4 1C.
The resulting supernatant was collected as the cytosol/membrane
(non-desmosomal) fraction. The Triton X-100-insoluble pellets
(containing desmosomal fractions) were solubilized in Laemmli
sample buffer containing 5% b-mercaptoethanol. Total protein was
determined by protein assay (RC-DC; Bio-Rad, Hercules, CA), and
approximately 25 mg of each sample fraction was separated by
SDS–PAGE. The gels were transferred to nitrocellulose, and
membranes were incubated with mouse anti-Dsg3 mAb 5G11
(Invitrogen), mouse monoclonal anti-desmocollin 3 (U114; Meridian
Life Science Inc.), mouse monoclonal anti-keratin (Zymed), or
mouse monoclonal anti-plakoglobin (11E4 anti-g catenin; Chemi-
con) diluted in PBS/5% milk. Blots were washed with PBS containing
0.1% Tween 20 and then incubated with either horseradish
peroxidase-conjugated goat anti-mouse (Bio-Rad) or donkey anti-
mouse (Jackson ImmunoResearch Labs Inc.) secondary antibodies
diluted in PBS/5% milk. Blots were developed using ECL Plus
reagent (Amersham Biosciences Corp., Buckinghamshire, UK).
Immunofluorescence microscopy studies
Primary human epidermal keratinocytes were seeded on coverslips
preincubated with collagen solution. For assembly experiments, cells
were treated with PV mAbs in DK-SFM containing 1.2mM calcium for
the indicated amount of time, and then fixed in PBS containing 4%
paraformaldehyde (freshly diluted from a 20% paraformaldehyde
solution; Electron Microscopy Sciences) for 20minutes at 4 1C, or with
ice-cold methanol or methanol/acetone (1:1) for 15minutes at 4 1C.
For cells fixed with 4% paraformaldehyde, a 10minutes incubation
with PBS containing 0.2% Triton X-100 was used for cell permeabi-
lization. Cells were blocked in PBS containing 2% BSA for 30minutes
at room temperature, followed by incubation with primary antibodies
in blocking solution for 1 hour at room temperature. After three
washes in PBS, cells were incubated with appropriately conjugated
secondary antibodies diluted 1:200 in blocking solution for
30–60minutes at room temperature. Nuclear staining was performed
with 46-diamidino-2-phenyl indole (DAPI; Sigma) or with ProLong
Gold anti-fade reagent with DAPI (Molecular Probes, Invitrogen).
Immunofluorescence was visualized with an Olympus BX61 micro-
scope. Images were acquired using Slidebook 4.2 software (Olympus)
and a Hamamatsu Orca ER camera, using consistent time exposures
among samples from each experiment. Nearest neighbor deconvolu-
tion was performed on the acquired images.
Antibody ELISA
Primary human epidermal keratinocytes were incubated with
100mgml1 pathogenic PV mAbs (P1 and P2) or nonpathogenic
antibodies (NP1 and NP2) in DK-SFM supplemented to 0.4mM
calcium. Culture medium (10 ml) was removed at time point 0, 2, 4,
6, 8, 12, 24, and 48 hours. The samples were immediately diluted in
Dsg3 ELISA sample diluent (MBL International Corp., Wobum, MA)
for a starting OD450 of approximately 0.5–1.0, stored at 4 1C until all
samples had been collected, then incubated on Dsg3 ELISA plates
according to the manufacturer’s directions. After washing, plates
were developed with horseradish peroxidase-conjugated anti-HA
antibody (3F10; Roche) and tetramethylbenzidine substrate. Absor-
bance was read at 450 nm.
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Electron microscopy
Confluent PHEK were seeded onto collagen-coated Permanox
removable chamber coverglass (LabTek, Campbell, CA) and grown
to confluence in DK-SFM, followed by a 1 hour incubation with PV
mAbs in DK-SFM supplemented to 1.2mM CaCl2. Cells were
prepared for transmission electron microscopy analysis according
to previously published methods (Allen et al., 1996; Dyer et al.,
2006). Briefly, at the end of antibody incubation, the cells were
washed in PBS and fixed with 2.5% glutaraldehyde and 2%
paraformaldehyde in 0.1M sodium cacodylate buffer for 1 hour.
The cells were postfixed with 1% osmium tetroxide and dehydrated
with ethanol. After infiltration, selected areas of the slide were
selected for flat embedding with premade blank epoxy blocks and
polymerized at 68 1C for 48 hours. One surface semithin section was
cut and stained with toluidine blue to screen the cell population, and
ultrathin sections were cut parallel to the culture surface. After stain
with uranyl acetate and lead citrate, the sections were examined
with a FEI Tecnai-T12 transmission electron microscope operated at
80 kv. To evaluate intercellular contact, random digital images
( 1,100) were taken from multiple mesh holes with a Gatan 2K
digital camera using image acquisition software (DigitalMicrograph)
from the same vendor.
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